NCT00003914View on ClinicalTrials.gov

Dolastatin 10 in Treating Patients With Advanced Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

August 31, 2002

Study Completion Date

May 31, 2009

Conditions
Kidney Cancer
Interventions
DRUG

dolastatin 10

Trial Locations (3)

32224

Mayo Clinic Jacksonville, Jacksonville

55905

Mayo Clinic Cancer Center, Rochester

85259

Mayo Clinic Scottsdale, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER